首页> 外文OA文献 >Nanocarriers, nanovaccines, and nanobacteria as nanobiotechnological concerns in modern vaccines
【2h】

Nanocarriers, nanovaccines, and nanobacteria as nanobiotechnological concerns in modern vaccines

机译:纳米载体,纳米疫苗和纳米细菌是现代疫苗中纳米生物技术关注的问题

摘要

This review briefly describes the concerns of nanobiotechnology in the design and development of novel vaccines using the most known nanocarriers, including nature-made nanocarriers (such as bacterial spores, virus-like particles, exosomes, and bacteriophages), man-made nanocarriers (such as Proteosomes, liposomes, virosomes, SuperFluids, and nanobeads), and their applications in therapeutic and protective immunization, as well as their advantages and disadvantages. Here, we focus on the development of nano-based vaccines as ''nanovaccines'' for inducing immune systems, and the foreseeable promises and problems when compared with existing vaccines. Also, we review a potential nano-hazard for vaccines, so-called nanobacterial contamination. © 2013 Sharif University of Technology. Production and hosting by Elsevier B.V. All rights reserved.
机译:这篇综述简要描述了纳米生物技术在使用最已知的纳米载体设计和开发新型疫苗中的关注点,这些载体包括天然纳米载体(例如细菌孢子,病毒样颗粒,外来体和噬菌体),人造纳米载体(例如(例如蛋白体,脂质体,病毒体,SuperFluid和Nanobeads),以及它们在治疗性和保护性免疫中的应用,以及它们的优缺点。在这里,我们专注于开发纳米​​疫苗作为诱导免疫系统的“ nanovaccines”,与现有疫苗相比,可预见的前景和问题。此外,我们还回顾了疫苗的潜在纳米危害,即所谓的纳米细菌污染。 ©2013 Sharif工业大学。 Elsevier B.V制作和托管。保留所有权利。

著录项

  • 作者

    Gill P.;

  • 作者单位
  • 年度 2013
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号